BDBM531876 3-(4-((4-((4'-fluoro-5,5-dimethyl-3,4,5,6- tetrahydro-[1,1'-biphenyl]-2- yl)methyl)piperazin-1-yl)methyl)-1- oxoisoindolin-2-yl)piperidine-2,6-dione::US20260028326, Compound GT-05393

SMILES CC1(C)CCC(CN2CCN(Cc3cccc4c3CN(C3CCC(=O)NC3=O)C4=O)CC2)=C(c2ccc(F)cc2)C1

InChI Key InChIKey=ADKGCMDIJVGVGQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 531876   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 531876BDBM531876(3-(4-((4-((4'-fluoro-5,5-dimethyl-3,4,5,6- tetrahy...)
Affinity DataIC50: 340nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center Affiliation: The Scripps Research Institute, TSRI Assay Provide...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2026
Entry Details
US Patent